エピレプシーおよび自閉症スペクトル障害におけるレヴェチラセタム:安全性,耐受性および有効性の分析

Jon Allard¹, William Henley², Brendan McLean¹

¹Cornwall Partnership NHS Foundation Trust, United Kingdom; University of Plymouth, United Kingdom.

Epilepsy & behavior : E&B

|August 29, 2025

まとめ

レベチラセタム (LEV) は,自閉症患者におけるの治療に効果があり,自閉症でない患者と同様の耐容性を示しています. 効果は自閉症の患者ではあまり顕著ではないが,LEVは有効な治療法である.

科学分野:

神経科学
神経発達障害
薬理学について

背景:

自閉症スペクトル障害 (ASD) の5人に1人が発症しています.
抗発作薬 (ASM) は一般的に使用されていますが,自閉症の個人に与える影響は十分に研究されていません.
レベチラセタム (LEV) は,エピレプシーに頻繁に処方されるASMです.

研究の目的:

エピレプシーを持つ自閉症患者におけるレヴェチラセタム (LEV) の有効性と耐性を評価する.
神経発達障害のある人とない人のASM反応を比較する.
自閉症患者におけるLEFの安全性と有効性を調査する.

主な方法:

イギリスのエピレプシー研究データベース登録 (2000-2020年) の175人の参加者の遡及分析.
自閉症と非自閉症のグループ間の離脱率,発作頻度,および有害効果を含む12ヶ月のASMデータの比較.
フィッシャーの正確なテストとロジスティック回帰を用いた統計的分析.

主要な成果:

自閉症と非自閉症の参加者間の離脱率やグループ化された副作用 (身体的/精神的健康) の有意な差異はありません.
自閉症は当初,LEVに対する攻撃性に関連していましたが,複数のテストの調整後,これは有意ではありませんでした.
LEVの有効性と自閉症群の間の有意な非線形関係 (P < 0. 001) が観察されました.

結論:

レベチラセタム (LEV) は,自閉症スペクトル障害の患者に対する適切な治療法です.
非自閉症の個人と比較して,耐受性や離脱率の有意な違いは見つかりませんでした.
効果は自閉症の個人にあまり顕著な変化を示さないかもしれませんが,LEVは有効な治療法です.

キーワード:

抗発作薬自閉症スペクトル障害エピレプシーレベチラセタム研究データベース

さらに関連する動画

10:46

Author Spotlight: Obtaining High-Quality CSF and Blood Samples for Epilepsy Biomarker Discovery

Published on: September 1, 2023

3.4K

05:33

A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus

Published on: June 23, 2022

2.9K

関連する概念動画

01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

445

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

445

01:20

Antiepileptic Drugs: Potassium Channel Activators

274

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...

274

01:24

Epilepsy and Seizures: Overview

275

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...

275

01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

635

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...

635

01:14

Antiepileptic Drugs: Glutamate Antagonists

511

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...

511

01:13

Seizures: Classification

584

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:

584

関連する実験動画